Bushu Pharmaceuticals to Construct New Hormone Manufacturing Facility.Tokyo, Japan, Aug 10, 2005 - (JCNN JCNN Japan Corporate News Network ) - Bushu Pharmaceuticals has begun constructing a new facility for manufacturing hormone agents. The facility, which will become operational in July 2006, will exclusively manufacture hormone agents in order to prevent crossover Crossover The point on a stock chart when a security and an indicator intersect. Crossovers are used by technical analysts to aid in forecasting the future movements in the price of a stock. In most technical analysis models, a crossover is a signal to either buy or sell. contamination with general drugs. The new facility will have high-speed PPT packaging lines, a blister blister, puffy swelling of the outer skin (epidermis) caused by burn, friction, or irritants like poison ivy. A response of the body to protect deeper tissue, blisters generally contain serum, the liquid component of blood. line and other filling machines. The company will invest approximately 900 million yen ($8 mil) in plant and equipment. With the new facility up and running, Bushu aims to bolster its presence in the field of hormone agents. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion